Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
glp-1 drug mounjaro Shortage of 'breakthrough' weight loss drugs will slow fight against obesity, WHO warns | Obesity Triple Receptor Agonist Sample collection:Walk-in clinic Retatrutide is a triple
Retatrutide is a triple agonist - GLP-1, GIP, and glucagon. In TRIUMPH-1, 2,339 adults with obesity (no diabetes) were randomized to 4, 9, or 12 mg, or placebo, for 80 weeks. On-treatment
GLP-1 indirectly supports hormonal balance by stabilizing insulin levels, improving metabolism, and reducing fat storage, which helps regulate estrogen and progesterone fluctuations
Triple Receptor Agonist
Sample collection:Walk-in clinic
2014:CD003824
US$ 22.62
US$ 24.60
US$ 28.52
US$ 29.26
US$ 23.09
US$ 22.76
